Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Vivid Vision licenses SUNY technology that uses VR capabilities to treat lazy eye

By Jesse Schwartz
Published: May 9th, 2018

Vivid Vision, a company that uses virtual reality technology to treat vision disorders, has signed a license agreement with the Research Foundation of the State University of New York (RFSUNY) to advance a new treatment for lazy eye.

Under the agreement, Vivid Vision will have access to a patented system developed by Benjamin Backus, associate professor at SUNY College of Optometry, that uses eye-tracking, a technology that is expected to play a crucial role in the development of the VR industry.

In gaming, eye-tracking will enable new features like virtual avatars with realistic eye movements. In his research, Backus has adapted the technology to stimulate binocular vision in the retinas of both eyes and teach neurons to work together as a lazy eye therapy. Backus now serves as chief science officer at Vivid Vision

“We believe eye tracking is integral to the next generation of treatment tools for binocular dysfunction such as amblyopia, strabsimus and convergence insufficiency,” says James Blaha, CEO of Vivid Vision. The company has raised over $2 million to advance its VR technologies to market.

Source: Upload

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment